RESEARCH TRIANGLE PARK, N.C., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today ...
Milestone Marks an Important Step in Achieving Fennec’s Mission of Expanding Access to PEDMARQSI to Cancer Patients Across the Globe at Risk of Hearing Loss ~ RESEARCH TRIANGLE PARK, N.C., Feb. 07, ...
At close: February 5 at 4:00:01 PM EST ...
These are the Contract Research Organisations, or CROs, who have managed to carve a niche out of providing solutions to drug companies cheaper than they can themselves. The roots of the current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback